Insider trades

Open-market buys and sales that US company officers, directors and 10% owners file, newest filing first.

Open-market buys: 977 trades; $2.1B in total
Open-market sales: 1,282 trades; $2.7B in total
Insiders filing: 576 insiders; Last 7 days
Companies with several buyers: 33; Last 7 days

Nuo Therapeutics AURX

		Trade type
David Emerson JordenCEO/CFO	Nuo TherapeuticsAURX	Open-market sale	25/11/28	25/12/03	200,000 sh	$1.50	$300,000	−9.3%
Charles E. Sheedy10% Owner	Nuo TherapeuticsAURX	Open-market buy	25/07/30	25/08/01	133,333 sh	$1.50	$199,999.5	+1.2%
Charles E. Sheedy10% Owner	Nuo TherapeuticsAURX	Open-market buy	24/09/18	24/09/19	125,000 sh	$0.75	$93,750	+1.1%
Charles E. Sheedy10% Owner	Nuo TherapeuticsAURX	Open-market buy	24/05/20	24/05/21	100,000 sh	$0.75	$75,000	+0.9%
Charles E. Sheedy10% Owner	Nuo TherapeuticsAURX	Open-market buy	23/12/19	23/12/20	150,000 sh	$0.50	$75,000	+1.4%
Charles E. Sheedy10% Owner	Nuo TherapeuticsAURX	Open-market buy	23/08/01	23/08/04	62,500 sh	$2.00	$125,000	+0.6%